News Sandoz Group AG

Equities

SDZ

CH1243598427

Market Closed - Swiss Exchange Other stock markets 09:01:03 29/05/2024 pm IST			5-day change	1st Jan Change
31.57 ^CHF	-2.23%		-1.59%	+16.67%

22/05	Sandoz: Marketing authorization for Wyost and Jubbonti in the EU	CF
22/05	Sandoz Group Receives EU Approval for Cancer, Osteoporosis Biosimilars	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sandoz receives European Commission approval for Wyost and Jubbonti, the first and only biosimilars of denosumab in Europe	23/05	AQ
European Commission grants first-of-a-kind biosimilar approval	23/05	AQ
Sandoz: Marketing authorization for Wyost and Jubbonti in the EU	22/05	CF
Sandoz Group Receives EU Approval for Cancer, Osteoporosis Biosimilars	22/05	MT
Sandoz receives European Commission approval for Wyost® and Jubbonti®, the first and only biosimilars of denosumab in Europe	22/05	GL
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	09/05	MT
AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents	09/05	MT
AstraZeneca, Merck Sue Over Alleged Cancer Drug Patents Infringement	08/05	MT
Swiss Market Index Closes Higher; Sandoz Gains	08/05	MT
SANDOZ : Sandoz’s improvements are worth betting on	08/05
SANDOZ : Q1 miss not a worry; expect another boost for the share price	07/05
Sandoz: 5% sales growth in Q1	07/05	CF
Transcript : Sandoz Group AG, Q1 2024 Sales/ Trading Statement Call, May 07, 2024	07/05
Sandoz Group Logs Growth in Q1 Net Sales, Affirms FY24 Outlook	07/05	MT
Sandoz reports first quarter 2024 sales	07/05	GL
Sandoz Announces Sales Results for the First Quarter 2024	07/05	CI
Sandoz Group Ag Reiterates Earnings Guidance for the Full Year 2024	07/05	CI
Global markets live: Adidas, Mercedes, McDonalds, Eli Lilly, PayPal, MicroStrategy, Tesla...	30/04
Sandoz Group AG Announces Appointment of Graeme Pitkethly as Non-Executive Director and Chair of Its Audit, Risk and Compliance Committee	30/04	CI
Shareholders approve all resolutions proposed by Board of Directors at Annual General Meeting of Sandoz Group AG	30/04	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SANDOZ : Sandoz’s improvements are worth betting on

May 08, 2024 at 05:38 pm IST